These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21507)

  • 1. Possible pathogenesis of Huntington's chorea and a new approach to treatment.
    Divac I
    Acta Neurol Scand; 1977 Oct; 56(4):357-60. PubMed ID: 21507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neocortical neurotransmitter markers in Huntington's disease.
    Pearson SJ; Reynolds GP
    J Neural Transm Gen Sect; 1994; 98(3):197-207. PubMed ID: 7748520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in L-glutamate binding in Alzheimer's and Huntington's diseases.
    Greenamyre JT; Penney JB; Young AB; D'Amato CJ; Hicks SP; Shoulson I
    Science; 1985 Mar; 227(4693):1496-9. PubMed ID: 2858129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurochemical substrates of rigidity and chorea in Huntington's disease.
    Storey E; Beal MF
    Brain; 1993 Oct; 116 ( Pt 5)():1201-22. PubMed ID: 7693298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of brain neurotransmitter receptor binding in Huntington's chorea.
    Enna SJ; Bennett JP; Bylund DB; Snyder SH; Bird ED; Iversen LL
    Brain Res; 1976 Nov; 116(3):531-7. PubMed ID: 10053
    [No Abstract]   [Full Text] [Related]  

  • 6. Dementia in Huntington's disease is associated with neurochemical deficits in the caudate nucleus, not the cerebral cortex.
    Reynolds GP; Pearson SJ; Heathfield KW
    Neurosci Lett; 1990 May; 113(1):95-100. PubMed ID: 1973277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional brain concentrations of neuropeptides in Huntington's chorea and schizophrenia.
    Nemeroff CB; Youngblood WW; Manberg PJ; Prange AJ; Kizer JS
    Science; 1983 Sep; 221(4614):972-5. PubMed ID: 6136092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormalities of neurotransmitter enzymes in Huntington's chorea.
    Wu JY; Bird ED; Chen MS; Huang WM
    Neurochem Res; 1979 Oct; 4(5):575-86. PubMed ID: 40150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Huntington's chorea. Changes in neurotransmitter receptors in the brain.
    Enna SJ; Bird ED; Bennett JP; Bylund DB; Yamamura HI; Iversen LL; Snyder SH
    N Engl J Med; 1976 Jun; 294(24):1305-9. PubMed ID: 4733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Letter: G.A.B.A. and Huntington's chorea.
    Barbeau A
    Lancet; 1973 Dec; 2(7844):1499-500. PubMed ID: 4129342
    [No Abstract]   [Full Text] [Related]  

  • 11. Depletion of monoamine transmitters by tetrabenazine in brain tissue in Huntington's disease.
    Pearson SJ; Reynolds GP
    Neuropharmacology; 1988 Jul; 27(7):717-9. PubMed ID: 2901681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurochemical-clinical correlates in Huntington's disease--applications of brain banking techniques.
    Reynolds GP; Pearson SJ
    J Neural Transm Suppl; 1993; 39():207-14. PubMed ID: 8103075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in 3H-GABA binding in Huntington's chorea.
    Lloyd KG; Dreksler S; Bird ED
    Life Sci; 1977 Sep; 21(5):747-53. PubMed ID: 198624
    [No Abstract]   [Full Text] [Related]  

  • 14. Amino acid neurotransmitter abnormalities in Huntington's disease and the quinolinic acid animal model of Huntington's disease.
    Ellison DW; Beal MF; Mazurek MF; Malloy JR; Bird ED; Martin JB
    Brain; 1987 Dec; 110 ( Pt 6)():1657-73. PubMed ID: 2892568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma choline and cholinergic mechanisms in the brain. Methods, function, and rôle in Huntington's chorea.
    Eckernäs SA
    Acta Physiol Scand Suppl; 1977; 449():1-62. PubMed ID: 143869
    [No Abstract]   [Full Text] [Related]  

  • 16. Editorial: Dopamine and G.A.B.A. in Huntington's chorea.
    Lancet; 1974 Nov; 2(7889):1122-3. PubMed ID: 4139415
    [No Abstract]   [Full Text] [Related]  

  • 17. [Recent neurobiological and related pharmaco-therapeutic acquisitions in Huntington's chorea].
    Carolei A; Del Castillo G
    Clin Ter; 1979 Sep; 90(6):591-621. PubMed ID: 43793
    [No Abstract]   [Full Text] [Related]  

  • 18. The therapeutic potential of G-protein coupled receptors in Huntington's disease.
    Dowie MJ; Scotter EL; Molinari E; Glass M
    Pharmacol Ther; 2010 Nov; 128(2):305-23. PubMed ID: 20708032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutamatergic therapy of Huntington's chorea.
    Giuffra ME; Mouradian MM; Chase TN
    Clin Neuropharmacol; 1992 Apr; 15(2):148-51. PubMed ID: 1350513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Several biochemical mechanisms of the pathogenesis of Huntington chorea].
    Barkhatova VP; Larskiĭ EG; Markova ED; Ivanova-Smolenskaia IA; Insarova NG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(7):1038-45. PubMed ID: 6137919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.